{"success":true,"data":{"pressRelease":{"id":"165869","rtpr_id":"nBw7TkdsBa-20261010","ticker":"CC","exchange":"NYSE","all_tickers":["CC"],"title":"CC Investors Have Opportunity to Lead The Chemours Company Securities Fraud Lawsuit with SBS Law","author":"Business Wire","published_at":"2026-10-10T20:10:00.083Z","article_body":"CC Investors Have Opportunity to Lead The Chemours Company Securities Fraud\nLawsuit with SBS Law\n\nSchall, Brown & Schwartz LLP\n(https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fschallfirm.com%2F&esheet=54619759&newsitemid=20261010317510&lan=en-US&anchor=Schall%2C+Brown+%26+Schwartz+LLP&index=1&md5=57cf8700cd5517a98d9493f8575be16e)\n(“SBS”), a national shareholder rights litigation firm, reminds investors\nof a class action lawsuit against The Chemours Company (“Chemours” or\n“the Company”) (NYSE: CC\n(https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.marketwatch.com%2Finvesting%2Fstock%2FCC&esheet=54619759&newsitemid=20261010317510&lan=en-US&anchor=CC&index=2&md5=1206455d5bc2e3747eb440ee390ea599)\n) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934\nand Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange\nCommission.\n\nShareholders who purchased shares of CC during the class period listed are\nencouraged to contact the firm regarding possible lead plaintiff appointments.\nAppointment as lead plaintiff is not required to partake in any recovery.\n\nCLASS PERIOD: February 20, 2026 to August 4, 2026\n\nDEADLINE: December 7, 2026\n\nIf you are a shareholder who suffered a loss, click here to participate\n(https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fschallfirm.com%2Fcases%2Fthe-chemours-company-4%2F&esheet=54619759&newsitemid=20261010317510&lan=en-US&anchor=click+here+to+participate&index=3&md5=74d8388ac9185c4ff30bd03b72f6a3d3)\n.\n\nCASE DETAILS: According to the Complaint, the Company made false and\nmisleading statements to the market. Chemours overstated the demand for its\nOpteon products. The Company suffered from slowing demand due to overselling\nin the prior year. The Company’s fiscal guidance for 2026 was unreliable.\nBased on these facts, the Company’s public statements were false and\nmaterially misleading throughout the class period. When the market learned the\ntruth about Chemours, investors suffered damages.\n\nWe also encourage you to contact Brian Schall or David Schwartz of Schall,\nBrown & Schwartz LLP, 2049 Century Park East, Suite 2460, Los Angeles, CA\n90067, at 310-301-3335, to discuss your rights free of charge. You can also\nreach us through the firm's website at www.schallfirm.com\n(https://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fpr.report%2FmIwBkOrU&esheet=54619759&newsitemid=20261010317510&lan=en-US&anchor=www.schallfirm.com&index=4&md5=fbeac049d87a35ffdfd6d751fa0bb216)\n, or by email at david@schallfirm.com (mailto:david@schallfirm.com) .\n\nThe class, in this case, has not yet been certified, and until certification\noccurs, you are not represented by an attorney. If you choose to take no\naction, you can remain an absent class member.\n\nJoin the case\n(https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fschallfirm.com%2Fcases%2Fthe-chemours-company-4%2F&esheet=54619759&newsitemid=20261010317510&lan=en-US&anchor=Join+the+case&index=5&md5=a011d996e250b19ca7b12c38bd659a57)\nto recover your losses\n\nWHY SBS? Schall, Brown & Schwartz LLP represents investors around the\nworld and specializes in securities class action lawsuits and shareholder\nrights litigation. Bringing together the extensive experience and diverse\nskillsets of founding partners Brian Schall, Andrew Brown, and David Schwartz,\nSBS is dedicated to aggressively advocating for every investor.\n\nThis press release may be considered Attorney Advertising in some\njurisdictions under the applicable law and rules of ethics.\n\n\n\nView source version on businesswire.com:\nhttps://www.businesswire.com/news/home/20261010317510/en/\n(https://www.businesswire.com/news/home/20261010317510/en/)\n\nSchall, Brown & Schwartz LLP\nBrian Schall, Esq.,\nAndrew Brown, Esq.,\nDavid Schwartz, Esq.,\nwww.schallfirm.com\n(https://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.schallfirm.com&esheet=54619759&newsitemid=20261010317510&lan=en-US&anchor=www.schallfirm.com&index=6&md5=8bbf3c92d04036aceb5b24287e11fa98)\n\nOffice: 310-301-3335\ninfo@schallfirm.com (mailto:info@schallfirm.com)\n\n\nCopyright Business Wire 2026","article_body_html":"","raw_payload":{"data":{"id":"nBw7TkdsBa-20261010","title":"CC Investors Have Opportunity to Lead The Chemours Company Securities Fraud Lawsuit with SBS Law","author":"Business Wire","ticker":"CC","created":"2026-10-10T20:10:00.083Z","tickers":["CC"],"exchange":"NYSE","article_body":"CC Investors Have Opportunity to Lead The Chemours Company Securities Fraud\nLawsuit with SBS Law\n\nSchall, Brown & Schwartz LLP\n(https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fschallfirm.com%2F&esheet=54619759&newsitemid=20261010317510&lan=en-US&anchor=Schall%2C+Brown+%26+Schwartz+LLP&index=1&md5=57cf8700cd5517a98d9493f8575be16e)\n(“SBS”), a national shareholder rights litigation firm, reminds investors\nof a class action lawsuit against The Chemours Company (“Chemours” or\n“the Company”) (NYSE: CC\n(https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.marketwatch.com%2Finvesting%2Fstock%2FCC&esheet=54619759&newsitemid=20261010317510&lan=en-US&anchor=CC&index=2&md5=1206455d5bc2e3747eb440ee390ea599)\n) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934\nand Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange\nCommission.\n\nShareholders who purchased shares of CC during the class period listed are\nencouraged to contact the firm regarding possible lead plaintiff appointments.\nAppointment as lead plaintiff is not required to partake in any recovery.\n\nCLASS PERIOD: February 20, 2026 to August 4, 2026\n\nDEADLINE: December 7, 2026\n\nIf you are a shareholder who suffered a loss, click here to participate\n(https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fschallfirm.com%2Fcases%2Fthe-chemours-company-4%2F&esheet=54619759&newsitemid=20261010317510&lan=en-US&anchor=click+here+to+participate&index=3&md5=74d8388ac9185c4ff30bd03b72f6a3d3)\n.\n\nCASE DETAILS: According to the Complaint, the Company made false and\nmisleading statements to the market. Chemours overstated the demand for its\nOpteon products. The Company suffered from slowing demand due to overselling\nin the prior year. The Company’s fiscal guidance for 2026 was unreliable.\nBased on these facts, the Company’s public statements were false and\nmaterially misleading throughout the class period. When the market learned the\ntruth about Chemours, investors suffered damages.\n\nWe also encourage you to contact Brian Schall or David Schwartz of Schall,\nBrown & Schwartz LLP, 2049 Century Park East, Suite 2460, Los Angeles, CA\n90067, at 310-301-3335, to discuss your rights free of charge. You can also\nreach us through the firm's website at www.schallfirm.com\n(https://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fpr.report%2FmIwBkOrU&esheet=54619759&newsitemid=20261010317510&lan=en-US&anchor=www.schallfirm.com&index=4&md5=fbeac049d87a35ffdfd6d751fa0bb216)\n, or by email at david@schallfirm.com (mailto:david@schallfirm.com) .\n\nThe class, in this case, has not yet been certified, and until certification\noccurs, you are not represented by an attorney. If you choose to take no\naction, you can remain an absent class member.\n\nJoin the case\n(https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fschallfirm.com%2Fcases%2Fthe-chemours-company-4%2F&esheet=54619759&newsitemid=20261010317510&lan=en-US&anchor=Join+the+case&index=5&md5=a011d996e250b19ca7b12c38bd659a57)\nto recover your losses\n\nWHY SBS? Schall, Brown & Schwartz LLP represents investors around the\nworld and specializes in securities class action lawsuits and shareholder\nrights litigation. Bringing together the extensive experience and diverse\nskillsets of founding partners Brian Schall, Andrew Brown, and David Schwartz,\nSBS is dedicated to aggressively advocating for every investor.\n\nThis press release may be considered Attorney Advertising in some\njurisdictions under the applicable law and rules of ethics.\n\n\n\nView source version on businesswire.com:\nhttps://www.businesswire.com/news/home/20261010317510/en/\n(https://www.businesswire.com/news/home/20261010317510/en/)\n\nSchall, Brown & Schwartz LLP\nBrian Schall, Esq.,\nAndrew Brown, Esq.,\nDavid Schwartz, Esq.,\nwww.schallfirm.com\n(https://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.schallfirm.com&esheet=54619759&newsitemid=20261010317510&lan=en-US&anchor=www.schallfirm.com&index=6&md5=8bbf3c92d04036aceb5b24287e11fa98)\n\nOffice: 310-301-3335\ninfo@schallfirm.com (mailto:info@schallfirm.com)\n\n\nCopyright Business Wire 2026"},"type":"article","timestamp":"2026-10-10T20:10:00.124329467Z","server_sent_at_ms":1791663000124},"received_at":"2026-10-10T20:10:00.175Z","source_url":"https://www.businesswire.com/news/home/20261010317510/en/"},"analysis":{"id":"154252","press_release_id":"165869","analysis_json":{"redFlags":["Securities fraud class action alleges overstated Opteon demand and unreliable FY2026 guidance","Class period Feb 20, 2026 to Aug 4, 2026; lead plaintiff deadline Dec 7, 2026"],"eventType":"legal_litigation","narrative":"Schall, Brown & Schwartz LLP issued a solicitation notice reminding Chemours (NYSE: CC) investors of a securities fraud class action covering the class period of February 20, 2026 to August 4, 2026, with a lead plaintiff deadline of December 7, 2026.\n\nThe complaint alleges Chemours overstated demand for its Opteon products and issued unreliable fiscal 2026 guidance amid slowing demand from prior-year overselling.\n\nThis is law-firm marketing, not an issuer disclosure or court action; the class has not yet been certified, so treat as low-signal noise.","sentiment":"neutral","agentHooks":{"shouldPost":false,"suggestedAngle":"Plaintiff-firm solicitation -- suppress."},"keyFigures":{},"namedEntities":{"people":[{"name":"Brian Schall","role":"founding partner, Schall, Brown & Schwartz LLP"},{"name":"Andrew Brown","role":"founding partner, Schall, Brown & Schwartz LLP"},{"name":"David Schwartz","role":"founding partner, Schall, Brown & Schwartz LLP"}],"products":["Opteon"],"companies":[{"name":"Schall, Brown & Schwartz LLP","relationship":"plaintiff law firm"},{"name":"The Chemours Company","ticker":"CC","relationship":"defendant/issuer"}],"dollarAmounts":[]},"materialImpact":{"score":1,"reasoning":"Plaintiff law-firm solicitation by Schall, Brown & Schwartz LLP reminding investors of a pending securities class action and lead-plaintiff deadline. No new issuer disclosure, no certified class, no settlement."},"tickerRelevance":{"others":[],"primary":"CC"},"globalImportance":15,"audienceRelevance":15,"eventTypeSecondary":[],"importanceComponents":{"tickerTier":"mid-cap","eventGravity":"law-firm-solicitation","issuerAuthored":false}},"event_type":"legal_litigation","event_type_secondary":null,"sentiment":"neutral","material_impact_score":1,"narrative":"Schall, Brown & Schwartz LLP issued a solicitation notice reminding Chemours (NYSE: CC) investors of a securities fraud class action covering the class period of February 20, 2026 to August 4, 2026, with a lead plaintiff deadline of December 7, 2026.\n\nThe complaint alleges Chemours overstated demand for its Opteon products and issued unreliable fiscal 2026 guidance amid slowing demand from prior-year overselling.\n\nThis is law-firm marketing, not an issuer disclosure or court action; the class has not yet been certified, so treat as low-signal noise.","key_figures":{},"named_entities":{"people":[{"name":"Brian Schall","role":"founding partner, Schall, Brown & Schwartz LLP"},{"name":"Andrew Brown","role":"founding partner, Schall, Brown & Schwartz LLP"},{"name":"David Schwartz","role":"founding partner, Schall, Brown & Schwartz LLP"}],"products":["Opteon"],"companies":[{"name":"Schall, Brown & Schwartz LLP","relationship":"plaintiff law firm"},{"name":"The Chemours Company","ticker":"CC","relationship":"defendant/issuer"}],"dollarAmounts":[]},"model_name":"glm-5.3-flashx","prompt_hash":"sha256:5c812bd9e28b810d","schema_hash":"sha256:05005c02d9cffac9","created_at":"2026-10-10T20:10:03.611Z","global_importance":15,"audience_relevance":15,"importance_components":{"tickerTier":"mid-cap","eventGravity":"law-firm-solicitation","issuerAuthored":false}},"durationMs":3422,"modelName":"glm-5.3-flashx"}}